Both in Biotechnology
Vericel vs Replimune Group
Over the past year VCEL returned +11.9% and REPL returned +121.9%; their daily moves had a correlation of -0.03.
VCEL +11.9% REPL +121.9%Growth of $1, one year, split-adjusted
| Metric | VCEL | REPL |
|---|---|---|
| Price | $41.09 | $20.65 |
| Market cap | $2.10B | $1.96B |
| Today | +1.43% | +5.95% |
| 1 month | 0.0% | +57.0% |
| 6 months | +11.6% | +619.5% |
| Year to date | +14.1% | +112.4% |
| 1 year | +17.2% | — |
| Revenue growth (YoY) | +22.5% | — |
| Gross margin | 72.8% | — |
| Net margin | 2.8% | — |
| P/E (TTM) | 86.9× | — |
| Price / sales | 6.9× | — |
| Net cash | $162.5M | $183.7M |
| Dividend yield | — | — |
| Volatility (60d) | 32.8% | 77.7% |
| Short % of float | 11.1% | 29.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).